Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 11, 2004, Pages 2293-2306

  Kim, Jeong Ran ^a   Kim, Cheorl Ho ^a  

^a Min Sci Technol Dept Biochem M   (South Korea)

Author keywords

ECM; extracellular matrix; HBV; HCC; hepatitis B virus; hepatocellular carcinoma; LC; liver cirrhosis; matrix metalloproteinases; membrane type MMP; MMP; MT MMP; reverse transcriptase polymerase chain; RT PCR; TIMP; tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; ZYMOGRAPHY;

CARCINOMA, HEPATOCELLULAR; ENZYME ACTIVATION; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

HEPATITIS B VIRUS;

EID: 4143072599     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.04.022     Document Type: Article

References (52)

1. Aimes R.T., Li L., Weaver B., Hawkes S., Hahn-Dantona E., Quigley J.P. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts. J. Cell Physiol. 174:1998;342-352
2. Apte S.S., Olsen B.J., Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270:1995;14313-14318
3. Arii S., Mise M., Harada T., Furutani M., Ishigami S.I., Niwano M., et al. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology. 24:1996;316-322
4. Benn J., Schneider R.T. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11215-11219
5. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4293-4297
6. Bigg H.F., Shi Y.E., Liu Y.E., Steffensen B., Overall C.M. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J. Biol. Chem. 272:1997;15496-15500
7. Boker K.H., Pehle B., Steinmetz C., Breitenstein K., Bahr M., Lichtinghagen R. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis. Hepatogastroenterology. 47:2000;812-819
8. Brooks P.C., Stromblad S., Sanders L.C., von Shalscha T.L., Aimes R.T., Stetler-Stevenson W.G., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85:1996;683-693
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159
10. Chung T.W., Moon S.K., Lee Y.C., Kim J.G., Ko J.H., Kim C.H. Enhanced expression of matrix metalloproteinase-9 (MMP-9) by hepatitis B virus (HBV) infection into liver cells. Arch. Biochem. Biophys. 408:2002;147-154
11. Chung T.W., Lee Y.C., Ko J.H., Kim C.H. Hepatitis B virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res. 63:2003;3453-3458
12. Collier I.E., Wilhelm S.M., Eisen A.Z., Marmer B.L., Grant G.A., Seltzer J.L., et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263:1988;6579-6587
13. Crawford H.C., Matrisian L.M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis. 14:1995;234-245
14. Garbisa S., Pozzatti R., Muschel R.J., Saffiotti U., Ballin M., Goldfarb R., et al. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res. 47:1987;1523-1528
15. Goldberg G.I., Marmer B.L., Grant G.A., Eisen A.Z., Wilhelm A., He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8207-8211
16. Goldberg G.I., Strongin A., Collier I.E., Genrich L.T., Marmer B.L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:1992;4583-4591
17. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur. J. Cell Biol. 74:1997;111-122
18. Granem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:1987;651-695
19. Hayasaka A., Suzuki N., Fusimoto N., Iwama S., Fukuyama E., Kanda Y., et al. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology. 24:1996;1058-1062
20. Hicks N.J., Ward R.V., Reynolds J.J. A fibrosarcoma model derived from mouse embryo cells: Growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell lines. Int. J. Cancer. 33:1984;835-844
21. Hildt E., Hofschneider P., Urban S. The role of hepatatitis B virus (HBV) in the development of hepatocellular carcinoma. Virology. 7:1996;333-347
22. Hildt E., Hofschneider P.H., Urban S. Isolation of highly purified, functional carboxy-terminally truncated hepatitis B virus middle surface protein activators from eucaryotic expression systems. Hepatology. 24:1996;502-507
23. Himelstein B.P., Canete-Soler R., Bernhard E.J., Dilks D.W., Muschel R.L. Metalloproteinases in tumor progression: The contribution of MMP-9. Invest. Methods. 14:1995;246-258
24. Johnson L.L., Dyer R., Hupe D.J. Matrix metalloproteinases. Curr. Opin. Chem. Biol. 2:1998;466-471
25. Kim T., Yu W., Kovalski K., Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 94:1998;353-362
26. Kondapaka S.B., Fridman R., Reddy K.B. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer. 70:1997;722-726
27. Kranzhofer A., Baker A.H., George S.J., Newby A.C. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb. Vasc. Biol. 19:1999;255-265
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
29. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell. Biol. 113:1991;437-449
30. Lichtinghagen R., Huegel O., Seifert T., Haberkorn C.I., Michels D., Flemming P., et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin. Chem. 46:2000;183-192
31. Lin L., Ke Y., Ko Y., Lin J. Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology. 55:1998;349-353
32. Lindsay C.K., Thorgeirsson U.P. Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Clin. Exp. Metastasis. 13:1995;381-388
33. Lowry O.H., Rosenbrough N.H., Farr A.L., Randall H. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
34. Mackay A.R., Hartzler J.L., Pelina M.D., Thorgeirsson U.P. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. Biol. Chem. 265:1990;21929-21934
35. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125
36. Moll V.M., Youngleib G., Rosinski K., Quigley J.P. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50:1990;6162-6170
37. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: Role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 301:2003;1069-1078
38. Natoli G., Avantaggiati M.L., Chirillo P., Puri P.L., Ianni A., Balsano C., et al. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene. 9:1994;2837-2843
39. Natoli G., Avantaggiati M.L., Chirillo P., Costanzo A., Artini M., Balsano C., et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell. Biol. 14:1994;989-998
40. Partridge C.A., Phillips P.G., Niedbala M.J., Jeffrey J.J. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am. J. Physiol. 272:1997;L812-L822
41. Paterlini P., Poussin K., Kew M., Franco D., Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321
42. Sato H., Takino T., Okada Y., Cao J., Shinigawa A., Yamamoto E., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65
43. Schnaper H.W., Grant D.S., Stetler-Stevenson W.G., Fridman R., D'orazi G., Murphy A.N., et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell Physiol. 156:1993;235-246
44. Shim J.K., Park C., Song E.Y., Lee Y.C., Chung T.W., Kim C.H. Differential expression of N-acetylglucosaminyltransferase-III and V activities in human hepatoma cells and colon cancer cells: Implication of cancer specific-glycoantigen systhesis in malignamt transformation. Kor. J. Chitin Chitosan. 2:1997;27-39
45. Shim J.K., Kim D.W., Chung T.H., Kim J.K., Suh J.I., Park C., et al. Characterization of a cell line HFH-T2, producing viral particles, from primary human fetal hepatocytes infected with hepatitis B virus. J. Microbiol. Biotechnol. 11:2001;186-192
46. Song E.Y., Lee Y.C., Park Y.G., Chung T.H., Kwon D.H., Byun S.M., et al. Expression of bisecting N-acetylglucosaminyltransferase-III in human hepatoma cell lines of Hep3B and HepG2. Cancer Investigation. 19:2001;799-807
47. Stearns M.E., Wang M. Type IV collagenase (M(r) 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res. 53:1993;873-883
48. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Met. Rev. 9(4):1990;289-303
49. Stetler-Stevenson W.G., Liotta L.A., Kleiner D.E. Jr. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441
50. Templeton N.S., Stetler-Stevenson W.G. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res. 51:1991;6190-6193
51. Wilhilm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:1989;17213-17221
52. Yamamoto M., Mohanam S., Sawaya R., Fuller G.N., SeiKi M., Sato H., et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:1996;384-392